Showing 1 - 8 results of 8 for search 'Khurram Jamil', query time: 0.04s
Refine Results
-
1
Pharmacokinetic and pharmacodynamic analyses of terlipressin in patients with hepatorenal syndrome by Xiaofeng Wang, Khurram Jamil
Published 2022-04-01
Article -
2
-
3
-
4
-
5
Pharmacokinetics/pharmacodynamics of L‐ornithine phenylacetate in overt hepatic encephalopathy and the effect of plasma ammonia concentration reduction on clinical outcomes by Rifaat Safadi, Robert S. Rahimi, Dominique Thabut, Jasmohan S. Bajaj, Kalyan Ram Bhamidimarri, Nikolaos Pyrsopoulos, Amy Potthoff, Stan Bukofzer, Laurene Wang, Khurram Jamil, Krishna R. Devarakonda
Published 2022-06-01
Article -
6
Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older by Muhammad A. Mujtaba, Ann Kathleen Gamilla-Crudo, Shehzad N. Merwat, Syed A. Hussain, Michael Kueht, Aftab Karim, Muhammad W. Khattak, Peggy J. Rooney, Khurram Jamil
Published 2023-09-01
Article -
7
Defining Renal Recovery in Patients With Hepatorenal Syndrome‐Acute Kidney Injury: Experience From North American Studies by Muhammad A. Mujtaba, Hussien Elsiesy, Sara Faiz, Syed A. Hussain, Ann Kathleen N. Gamilla‐Crudo, Aftab Karim, Mohammad Irfan Khan, Muhammad Waqar Khattak, Zunaira Zafar, Michael Kueht, Khurram Jamil
Published 2024-12-01
Article -
8
INFUSE: Rationale and design of a multi-center, open label, collaborative study to treat HRS-AKI with continuous terlipressin infusion by Ethan Weinberg, Suditi Rahematpura, Stevan A. Gonzalez, Manhal J. Izzy, Douglas A. Simonetto, R. Todd Frederick, Raymond A. Rubin, Jade Ikahihifo-Bender, Maggie Harte, Grace Kim-Lee, Sherry Witkiewicz, William Tobin, Khurram Jamil, Zachary Fricker, K. Rajender Reddy
Published 2023-12-01
Article